PLUX - WIRELESS BIOSIGNALS S.A.

Their core work

PLUX develops wireless biosignal acquisition hardware and software for health monitoring, wearable sensing, and physiological data collection. Their core product line enables researchers and clinicians to capture real-time body signals (EMG, ECG, EEG, EDA) through compact, wireless devices. Across H2020, they contribute wearable sensor technology to projects spanning chronic disease management, Parkinson's detection, autism therapy, nutrition monitoring, and first responder training. They sit at the intersection of medical-grade sensing hardware and the software platforms needed to interpret that data in clinical and everyday settings.

What they specialise in

How they've shifted over time

In the early period (2015-2018), PLUX focused on clinical health applications — integrated care for chronic patients, gamification for self-management, and unobtrusive behavioral sensing for Parkinson's detection. From 2020 onward, their scope broadened considerably: personalized nutrition, autism therapy with companion robots, mixed-reality first responder training, and electromagnetic safety of medical devices. The shift reveals a company moving from pure health monitoring into adjacent domains (security, food, advanced materials) where their wearable sensing expertise applies, while also investing in the regulatory and commercialization side of their technology.

PLUX is expanding from healthcare-only wearables into broader application domains (security, nutrition, assistive tech) while building expertise in electromagnetic safety — positioning themselves as a versatile biosignal platform provider rather than a single-sector device maker.

How they like to work

PLUX operates exclusively as a participant, never as coordinator, across all 9 projects — they are a technology supplier that plugs their wearable hardware into larger research efforts led by others. With 110 unique partners across 21 countries, they maintain a wide and non-repetitive network, joining diverse consortia rather than sticking with the same partners. This makes them an experienced, low-friction partner who knows how to integrate into different consortium structures and deliver their specific technical component reliably.

With 110 unique consortium partners spread across 21 countries, PLUX has built one of the broader collaboration networks you'd expect from a technology SME. Their partnerships span Western and Southern Europe heavily, consistent with their Lisbon base, but extend across the continent.

What sets them apart

PLUX brings production-ready wireless biosignal hardware to EU consortia — not just prototypes, but commercial devices already on the market. This means projects get a technology partner that can deliver functional wearable sensors from day one, rather than spending years developing hardware from scratch. For consortium builders, they offer a rare combination: a Portuguese SME with deep hardware expertise, commercial products, and a proven track record of delivering across 9 diverse H2020 projects.

Highlights from their portfolio

• POLYCARE
  Largest single funding (EUR 499K) — demonstrated PLUX's core value proposition of wearable sensors for chronic disease management with gamification.
• i-PROGNOSIS
  Tackled early Parkinson's detection through unobtrusive behavioral sensing via everyday smart device interactions — a technically ambitious application of their sensing capabilities.
• MED1stMR
  Expanded PLUX into the security/emergency sector, combining smart wearables with mixed-reality training for first responders — their highest-funded recent project (EUR 470K).